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We analyzed the influence of the transcription
factor DFosB on learned helplessness, an ani-
mal model of affective disorder wherein a sub-
set of mice exposed to inescapable stress (IS)
develop a deficit in escape behavior. Repeated
IS induces DFosB in the ventrolateral periaque-
ductal gray (vlPAG), and levels of the protein are
highly predictive of an individual’s subsequent
behavorial deficit—with the strongest DFosB
induction observed in the most resilient ani-
mals. Induction of DFosB by IS predominates
in substance P-positive neurons in the vlPAG,
and the substance P gene, a direct target for
DFosB, is downregulated upon DFosB induc-
tion. Local overexpression of DFosB in the
vlPAG using viral-mediated gene transfer dra-
matically reduces depression-like behaviors
and inhibits stress-induced release of sub-
stance P. These results indicate that IS-induced
accumulation of DFosB in the vlPAG desensi-
tizes substance P neurons enriched in this
area and opposes behavioral despair by pro-
moting active defense responses.
INTRODUCTION
Members of the Fos family of proteins are induced in the
brain upon neuronal activation. By dimerizing with mem-
bers of the Jun family, Fos proteins participate in the for-
mation of activator protein-1 (AP-1) transcription factor
complexes, which bind to DNA at AP-1 sites and modulate
the activity of target gene promoters (Morgan and Curran,
1995; Pennypacker, 1998). AP-1-mediated control of tran-
scription has been established as a critical mechanism
through which gene expression, and synaptic strength,can be regulated in an experience-dependent manner
(Sanyal et al., 2002). Genes encoding Fos and Jun family
proteins have been termed immediate early genes, owing
to their rapid and transient pattern of induction. However,
a subclass of stable Fos-related antigens (FRAs) was later
identified in the brain (Chen et al., 1995; Hope et al., 1994).
We now know that these chronic FRAs are composed of
stabilized isoforms of DFosB (Hiroi et al., 1997, 1998),
a truncated splice variant of FosB that lacks 101 amino
acids from the C-terminal end of the full-length protein
(Nakabeppu and Nathans, 1991; Yen et al., 1991). Con-
trary to FosB and all other Fos family proteins, DFosB
persists in brain for an extended period of time, and
accumulates to high levels in neurons after repeated stim-
ulation by the same stimulus (see McClung et al., 2004;
Nestler et al., 2001). These unique biochemical features
make DFosB an attractive candidate for mediating long-
term neuroadaptations in the brain.
Recently, we have shown that exposure to repeated
stress causes DFosB to accumulate in several brain re-
gions implicated in emotional learning (Perrotti et al.,
2004). Here, we further examined the role of DFosB in pro-
cesses of emotional adaptation using models of inescap-
able stress (IS). Repeated experiences of IS in mice dis-
rupts their ability to later express efficient fight/flight
responses. This behavioral plasticity process, referred to
as ‘‘learned helplessness,’’ is sensitive to antidepressants,
and is considered a well validated model of affective dis-
order in rodents. Neuroanatomical pathways mediating
learned helplessness have been partly established, and
involve monoaminergic systems (Amat et al., 2005; Bes-
son et al., 1998; Takase et al., 2004, 2005). Therefore,
we focused our analysis on three major monoaminergic
cell groups: the dorsal raphe nucleus (DR), ventral teg-
mental area (VTA), and locus coeruleus (LC). Based on
the results presented here, we propose that stress-
induced expression DFosB is part of an adaptive mecha-
nism that promotes resilience to IS by inhibiting selective
circuits in the brainstem that mediate the expression of
passive defense behaviors.Neuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc. 289
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Stress-Induced DFosB Promotes Active DefenseFigure 1. Escape Deficit and DFosB Accumulation in the
vlPAG after IS
(A) IS-induced escape deficits in mice. (Left) Escape latency across 15
escape trials. (Right) Distribution of the average latency during the last
five trials and median split (red line) used to discriminate between Es-
cape deficit versus No escape deficit groups. No-IS group, n = 7, IS
group, n = 28, *p < 0.05 versus IS-escape deficit, #p < 0.05 versus no-IS.
(B)DFosB accumulation in vlPAG. Top: (Left) Immunolabeling forDFosB
and (right) tryptophan hydroxylase (TPH). Bottom: (Left) Overlay and
(right) coronal view corresponding to AP coordinate 4.36 mm relative
to bregma. Aq, aqueduct; DR, dorsal raphe; mlf, medial longitudinal
fasciculus.
(C) (Left) DFosB accumulates most intensely in the area corresponding
to the rostral portion of the DR in IS-no escape deficit group (ANOVA290 Neuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc.RESULTS
Heterogeneous Escape Deficits Induced by IS
in Mice
Mice with no experience of IS (no-IS group, n = 7)
displayed consistently short escape latencies and an
absence of escape failures across 15 successive escape
trials (average escape latency: 3 ± 0 s, escape failures:
0% ± 0%). In the IS group (n = 28), repeated administration
of IS resulted in an overall increase in escape latencies
(14 ± 1 s, p < 0.001) and an increased proportion of escape
failures (44% ± 6%, p < 0.01). Individual responses were
highly heterogeneous within the IS group, especially
during the last trials of the test session, as indicated by
the striking spread in the average escape latencies for
the last five sessions (Figure 1A, right panel). A median
split of the average latency for the last five trials defines
two subgroups of animals that display dramatically diver-
gent patterns of responses within the IS group. One
subgroup (IS-escape deficit) showed an escape deficit
that was sustained across the 15 trials, whereas the other
subgroup (IS-no escape deficit) recovered escape laten-
cies identical to those of the no-IS group by the end
of the test session (Figure 1A, left panel; two-way ANOVA,
significant trial x subgroup interaction F28,448 = 2.48,
p < 0.001).
IS Induces DFosB Accumulation in Monoaminergic
Regions
We found a robust increase in the number of FosB immu-
noreactive cell nuclei in the DR and LC 24 hr after repeated
IS, but no change in the VTA (Figure 1B and Figure S2 in
the Supplemental Data, available with this article online).
Since the anti-FosB antibody used here targets an epitope
common to both DFosB and full-length FosB, and thus
does not allow us to differentiate between the two iso-
forms, we demonstrated in an additional experiment that
FosB immunoreactivity at this time point reflects the accu-
mulation of DFosB and not FosB (see Figure S1). Thus, no
immunolabeling was observed in the same brain sections
when an anti-FosB (C terminus) (Perrotti et al., 2005)
antibody was used, which recognizes an epitope present
only in the full-length FosB protein. The ability of the
anti-FosB (C terminus) antibody to effectively detect full-
length FosB was confirmed by detection of the protein in
mice sacrificed 3 hr after an acute exposure to inescap-
able foot shocks (Figure S1), when expression of the
full-length isoform is peaking. Similarly, DFosB accumula-
tion did not coincide with induction of c-Fos, which, like
full-length FosB, is a short-lived Fos family member
(Figure S1).
significant interaction between IS and rostrocaudal level, F12,104 =
21.33, p < 0.001, ***p < 0.001, **p < 0.01 versus IS-no escape deficit)
and correlates negatively with the severity of the behavioral deficit
(r = 0.69, p < 0.01, n = 18).
Data are expressed as mean ± SEM.
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Stress-Induced DFosB Promotes Active DefenseFigure 2. DFosB Accumulates in Sub-
stance P-Positive Neurons after IS
(A) Relative distribution of DFosB-positive cells
(visualized with DAB) and PPT-AmRNA (insert,
silver grains) in the vlPAG at 103 magnifica-
tion. The black arrow indicates the position of
the aqueduct on each view.
(B) (Left) Autoradiographs illustrating the rela-
tive distribution of SERT mRNA, GAD-67
mRNA, and PPT-A mRNA at the same rostro-
caudal level. The thin black arrows indicate
the position of the aqueduct on each view.
(Right) Examples of views (1003) used to
quantify mRNA grain density over DFosB-pos-
itive cells (black circles), DFosB-negative cells
(white circles), and background (red circle).
Arrowheads indicate cells which are either
positive (black) or negative (white) for a given
mRNA signal.
(C) Proportion of DFosB-positive cells cola-
beled with each type of probe in the vPAG;
note the major colocalization of DFosB-posi-
tive cells with PPT-A mRNA.
(D) Density of PPT-A silver grains is decreased
in DFosB-positive cells compared with DFosB-
negative cells; *p < 0.05.
Data are expressed as mean ± SEM.DFosB Levels in the Ventrolateral Periaqueductal
Gray Correlate Negatively with the Severity of the
Behavioral Deficit
The majority of FosB-like immunoreactivity induced in the
DR region was observed in the lateral margins of this
nucleus and comprised an area corresponding to the
ventrolateral periaqueductal gray (vlPAG). Comparison
ofDFosB levels in this area across the spectrum of escape
latencies (Figure 1A) indicates that mice from the IS-no
escape deficit group displayed significantly higher levels
of DFosB in the vlPAG compared with the animals from
the IS-escape deficit group (Figure 1C). A similar pattern
was seen for DFosB induction in the LC: DFosB levels
in IS-no escape deficit group were significantly greater
(26 ± 3 cells/mm2) than those of the IS-escape deficit
group (17 ± 3; p < 0.05).
Since the strongest induction ofDFosB was observed in
the vlPAG, as opposed to the LC (Figure S1A versus
Figure S1B), we performed a more detailed characteriza-
tion of the cell populations expressing DFosB in this re-
gion. Using tryptophan hydroxylase (TPH) as a marker of
serotonin neurons, we found that the highest degree of
DFosB accumulation occurs specifically at a rostrocaudal
level corresponding to the rostral portion of the DR (be-
tween 4.24 mm and 4.48 mm relative to bregma). At
this level, the number of cells immunoreactive for DFosB
correlates inversely with the severity of the behavioral def-
icit following IS (r = 0.69, p < 0.01, n = 18), with a lowerlevel ofDFosB accumulation being predictive of a stronger
escape deficit after IS (Figure 1C).
We performed a similar analysis in mice exposed to so-
cial defeat, another model of IS. In mice perfused 24 hr
after the last defeat episode, we also found an overall
increase in the number of DFosB-positive nuclei in the
vlPAG (ANOVA main effect, F2,47 = 3.34, p < 0.05). Inter-
estingly, as we had observed in the learned helplessness
paradigm, this effect was significant only in the subgroup
of resilient animals (Figure S3).
DFosB Is Induced Primarily in Substance P Neurons
in the vlPAG
We next investigated the cell type in the vlPAG in which IS
induced DFosB. By use of combined immunohistochem-
istry (for DFosB) and in situ hybridization (for substance
P mRNA), we found that a majority (63%) of DFosB-
positive cells also express substance P (Figures 2A–2C).
In contrast, much lower levels of colocalization were
observed between DFosB and serotonin (10%, using
serotonin transporter [SERT] mRNA as a marker) or
GABA (25%, using glutamic acid decarboxylase [GAD-
67] as a marker). All DFosB expression was neuronal,
since complete colocalization was observed with the neu-
ronal marker NeuN and no colocalization was observed
with glial fibrillary acidic protein (GFAP) (not shown). The
pattern of DFosB induction in nonserotonergic neurons
located at the periphery of the DR is similar to the patternNeuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc. 291
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Expression and Stress-Induced Sub-
stance P Release
(A) Viral overexpression of DFosB dose-
dependently inhibits PPT-A gene promoter
activity in luciferase reporter assays; *p < 0.05.
(B) ChIP from vlPAG demonstrates the direct
binding of DFosB (but not full-length FosB) to
the PPT-A gene promoter in vivo, 24 hr after
IS administration; *p < 0.05.
(C) In vivo microdialysis in freely moving rats.
Exposure to IS or forced swimming stress in-
creases substance P release in the NAc, an ef-
fect blocked by previous bilateral infusion of
HSV-DFosB in the vlPAG. ANOVA effect of
time (F11,165 = 6.74, p < 0.0001) and interaction
between virus and time (F11,165 = 2.07, p =
0.02), *p < 0.05 and **p < 0.01 from baseline,
#p < 0.05 and ##p < 0.01 from LacZ (n = 8–9
rats per group).
Data are expressed as mean ± SEM.observed in the LC. In this latter region most DFosB-
positive cells were seen just lateral to the boundary of
LC noradrenergic neurons, and very few DFosB-positive
cells colocalized with expression of the catecholaminergic
marker tyrosine hydroxylase (Figure S1).
DFosB Decreases Substance P Gene Expression
In Vitro and In Vivo
We tested whether IS-induced DFosB regulates sub-
stance P gene expression in three different ways. First
we analyzed levels of preprotachykinin A (PPT-A) mRNA,
the substance P precursor, over DFosB-positive and
DFosB-negative cells by use of a combined immunohisto-
chemistry-in situ hybridization method (Figure 2B). The
average density of substance P mRNA silver grains was
significantly lower over individual DFosB-positive cells
compared with DFosB-negative cells (ANOVA effect of
cell type, F2,228 = 27.8, p < 0.001) (Figure 2D). This result
led us to hypothesize that DFosB accumulation may con-
tribute to repress PPT-A gene transcription. We tested
this hypothesis in vitro by a using a promoter assay in
PC12 cells in which a luciferase reporter is placed under
the control of a 1.3 kb fragment of the PPT-A 50 gene
promoter. We found that overexpression of DFosB, using
a herpes simplex virus (HSV) viral vector, causes a dose-
dependent repression of the PPT-A promoter compared
with use of a control HSV-LacZ vector (ANOVA dose
effect, F2,5 = 5.55, p = 0.053) (Figure 3A).292 Neuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc.We next sought evidence as to whether this regulation
represents a direct effect of DFosB on the PPT-A gene.
To test this hypothesis, we performed chromatin immuno-
precipitation (ChIP) assays from vlPAG tissue in mice
killed 1 or 24 hr after administration of IS (n = 6 per group).
We observed a significant enrichment of the PPT-A gene
promoter (the region which contains its AP-1 sequences)
after immunoprecipitation of chromatin complexes for
DFosB (ANOVA main effect of stress, F1,20 = 4.99 p <
0.05), but not for full-length FosB (ANOVA no effect of
stress, F1,20 = 0.367, nonsignificant) (Figure 3C). This
effect reached significance only 24 hr after the administra-
tion of IS (p < 0.05). This result indicates that DFosB accu-
mulating in substance P-positive neurons in the vlPAG
after IS binds directly to the promoter region of the
PPT-A gene in vivo.
DFosB in the vlPAG Modulates Stress-Induced
Substance P Release in the Nucleus Accumbens
To test whether the regulation of substance P gene ex-
pression in vlPAG neurons by DFosB may contribute to
functional alterations of forebrain substance P neurotrans-
mission, we overexpressed DFosB (or an inactive LacZ
construct) locally within the vlPAG using HSV vectors
and looked for changes in substance P release in a known
projection area of these neurons, the nucleus accumbens
(NAc). To mimic the endogenous pattern of expression of
DFosB, viral infusions were aimed at the lateral margins of
Neuron
Stress-Induced DFosB Promotes Active Defensethe serotonergic cell population (Figure 6). We measured
substance P release, both under baseline conditions and
following stress exposure, using in vivo microdialysis in
freely moving animals. Baseline extracellular concentra-
tions of substance P in the NAc were not significantly al-
tered by DFosB overexpression (13.9 ± 3.0 fmol/dialysate
for the LacZ group and 13.5 ± 1.7 fmol/dialysate for the
DFosB group). In contrast, the substance P response to
stress and its return to baseline were significantly affected
by DFosB: ANOVA effect of time, F11,165 = 6.74, p <
0.0001; and interaction between virus and time, F11,165 =
2.07, p = 0.02) (Figure 3C). Foot shocks and swim stress
each significantly increased substance P efflux in the
NAc of LacZ-injected animals by 30% and 120%, respec-
tively. Overexpression of DFosB in the vlPAG significantly
attenuated the foot shock-induced and swim stress-
induced enhancement of substance P release in this brain
region (Figure 3C).
NK1 Receptor Blockade in the NAc Has
an Antidepressant-like Effect
Our results so far indicated that exposure to IS leads, in
resilient animals, to a strong induction of DFosB in the
vlPAG, and apparently to a desensitized substance P
input to the NAc. To further understand the functional
significance of this decreased substance P input, we
blocked substance P receptors in the NAc by administer-
ing RP67589, a selective NK1 receptor antagonist, prior to
the test session. We found that injection of RP67580,
either systemically or directly into the NAc, significantly re-
duced escape latencies (ANOVA main drug effect, F4,54 =
3.13, p < 0.05) (Figure 4). We observed a similar profile of
activity in this test after subchronic administration of the
traditional antidepressant desipramine (Figure 4). To-
gether, these results indicate that decreased substance
P signaling in the NAc exerts an antidepressant-like effect
Figure 4. NK1 Receptor Blockade in the NAc Has an Antide-
pressant-like Effect
The selective NK1 receptor antagonist RP67580, administered either
systemically or directly into the NAc, significantly reduced escape la-
tencies (ANOVA main drug effect, F4,54 = 3.13, p < 0.05), an effect
shared by the subchronic administration of the antidepressant desi-
pramine in this test. *p < 0.05 and **p < 0.01 from respective control
conditions. Intracerebral injection, n = 7 mice per group; systemic
drug injection, n = 17–18 group. Data are expressed as mean ± SEM.and promotes active escape responses in the learned
helplessness paradigm.
Overexpression of DFosB in the vlPAG Opposes
Behavioral Despair
To further test the hypothesis that DFosB induction in the
vlPAG modulates defense responses to IS, we manipu-
lated levels of DFosB or other AP-1-related transcription
factors in this brain region using HSV vectors, and we
evaluated behavioral responses after exposure to IS.
Mice that received intra-vlPAG injections with a control
HSV vector expressing LacZ displayed a significant in-
crease in escape latency and an increased proportion of
escape failures following IS in the learned helplessness
test (Figures 5A and 5B), a result in line with our previous
observation in noninjected mice (Figure 1). These findings
indicate that stereotaxic surgery and viral infection per se
do not affect IS-induced escape deficits. In contrast, mice
injected with HSV-DFosB showed less severe, and non-
significant, behavioral deficits after IS. This result is con-
sistent with the correlation observed previously and
provides direct evidence that induction of this transcrip-
tion factor in the vlPAG increases resilience to IS. Interest-
ingly, a similar effect was obtained after overexpression of
the truncated protein DJunD. In contrast, viral-mediated
overexpression of full-length FosB caused the opposite
effect and potentiated the severity of the IS-induced
escape deficit (Figures 5A and 5B). Importantly, none of
these viral vectors altered escape behaviors in the ab-
sence of IS administration, nor did they have any effects
on general locomotion, motor coordination, and sensitivity
to foot shocks (Figures 5C–5E). Moreover, a similar anti-
depressant-like effect of HSV-DFosB in the vlPAG was
observed in a second, well-validated model that is also
sensitive to antidepressant treatments, i.e., the forced
swimming test. As illustrated in Figure 6D, DFosB bilater-
ally injected in the vlPAG reduced floating behavior (p <
0.01) and increased time spent struggling (p < 0.05) and
swimming (p < 0.05) compared with control conditions.
DISCUSSION
We have reported recently that exposure to IS causes
DFosB to accumulate in several brain regions implicated
in the expression of emotional responses (Perrotti et al.,
2004). The goal of the present study was to examine the
functional consequences of DFosB induction by IS.
Learned Helplessness: Neuroplasticity of Defense
Systems
Repeated exposure to IS in mice disrupts their ability to
later express active fight/flight responses in escapable sit-
uations (Chourbaji et al., 2005). This experience-depen-
dent shift from active defense to a passive behavioral rep-
ertoire (i.e., learned helplessness) occurs in some, but not
all, animals exposed to IS (Figure 1A) and can be corrected
by short-term treatment with a broad spectrum of antide-
pressants (Caldarone et al., 2000; Chourbaji et al., 2005)Neuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc. 293
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Stress-Induced DFosB Promotes Active DefenseFigure 5. Viral Overexpression ofDFosB in the vlPAGOpposes the Development of an IS-Induced Escape Deficit and Immobility in
the Forced Swimming Test
IS administration increased the percentage of escape failures (A) and average escape latency (B) in mice that received intra-vlPAG injections of the
control HSV-LacZ vector (n = 19), similar to results seen in noninjected animals (see Figure 1). In contrast, HSV-DFosB (n = 18), as well as HSV-DJunD
(n = 11), reduced the development of such escape deficits, while HSV-FosB (n = 12) had the opposite effect. ANOVA main effect of IS on escape
latency, F3,68 = 12.88, p < 0.001, and percentage of escape failures, F3,68 = 12.36, p < 0.001, *p < 0.05, ***p < 0.001 versus animals from the no-
IS condition. None of these viral vectors altered escape performances in the absence of IS administration. Overexpression of DFosB also decreased
immobility in the rat forced swimming test (C) (p < 0.01) while increasing time spent struggling (p < 0.05) and swimming (p < 0.05); n = 8–9 per group.
On the other hand, HSV-DFosB did not alter sensitivity to foot shocks (D), general locomotion (E), motor coordination (F), or social interactions (not
shown). Data are expressed as mean ± SEM.such as the tricyclic antidepressant desipramine used in
the present study (Figure 4). In the absence of treatment,
extinction of learned helplessness occurs after a short de-
lay in undisturbed animals (Chourbaji et al., 2005; Maier,
2001). However, exposure to contextual reminders stabi-
lizes escape deficits for several weeks after interruption
of the stress (Maier, 2001), an observation suggesting
that IS causes stable neuroplastic changes in neuronal
networks mediating defensive responses.
DFosB Accumulates in the DR and LC, but Not
in the VTA, after Repeated IS
We show here that DFosB accumulates in the DR and LC,
but not in the VTA, after repeated administration of IS. A
previous study reported an identical pattern of induction
of c-Fos upon re-exposure to an environment previously
associated with IS (Ishida et al., 2002). Taken together,
these results suggest a preferential involvement of se-
rotonergic and noradrenergic versus dopaminergic cell
groups in the associative processes supporting the devel-
opment of learned helplessness.294 Neuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc.DFosB Induction in the DR Area Predicts Individual
Degrees of Resilience to IS
It is important to point out that, in our study, increased
levels of DFosB were observed in mice perfused 24 hr af-
ter the last administration of repeated IS, and immediately
after a brief ‘‘escapable’’ test session. In these conditions,
we presumed that the FosB accumulation is caused by the
repeated IS administered 24 and 48 hr beforehand, and
not by the brief test session performed 15 min preceding
perfusion (which would not allow sufficient time for new
protein synthesis). This was confirmed by the observation
that mice from the no-IS-yoked group, which received no
repeated IS during the training session but the same
amount of foot shocks as the IS animals during the test
session, showed virtually no DFosB accumulation (Fig-
ure 1C). We also demonstrated that the FosB/DFosB sig-
nal 24 hr after IS reflects the accumulation of the stable,
truncated isoform DFosB, and not full-length FosB (Fig-
ure S1). These results are in good agreement with the
patterns of expression of DFosB that we have reported
earlier in other brain regions in response to stressors
Neuron
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in the vlPAG
Example of HSV-DFosB infection in the vlPAG.
The injections were aimed at the lateral mar-
gins of the DR in order to mimic the endoge-
nous pattern of DFosB induction after IS (see
Figure 1B and Figure S1). (A) Serotonergic neu-
rons were immunolabeled with an antibody
against tryptophan hydroxylase, and (B) the vi-
ral overexpression was revealed with an anti-
body against DFosB. The overlays at low (C)
and high (D) magnification confirm the location
of the infection at the lateral margins of the se-
rotonergic cell groups (D). Dashed triangles in-
dicate the position of the aqueduct on each
picture.and many other types of stimuli (McClung et al., 2004;
Perrotti et al., 2004, 2005).
In the region where the highest degree of induction is
observed (the vlPAG, corresponding to the rostral portion
of the DR), the number of cells immunopositive for DFosB
was inversely proportional to the severity of the escape
deficit after IS (Figure 1C). In other words, the level of
DFosB induction by IS in this brain region predicts the
individual degree of resilience to IS. To test whether this
pattern of DFosB expression is produced specifically by
the learned helplessness paradigm (or whether it may
result from exposure to other types of repeated IS), we
evaluated DFosB levels in the vlPAG of mice subjected
to another IS paradigm which elicits learned effects that
are sensitive to antidepressants. Using a repeated social
defeat paradigm, which also triggers long-lasting alter-
ations of defense responses (Berton et al., 2006), we
observed a similar relationship between the level ofDFosB
in the vlPAG and the individual degrees of resilience (see
Figure S1). This observation suggests that DFosB induc-
tion may constitute a signature neuroadaptation in de-
fense circuits that is uniquely linked to the development
of resilience to IS. The origin of the behavioral and physi-
ological interindividual variations observed here is un-
known. Since our experimental population is composed
of inbred mice, these variations cannot be attributed to
genetic heterogeneity, but may reflect epigenetic, sto-
chastic, or environmental influences (Maier and Watkins,
2005).
DFosB Induction Occurs in Passive Coping-Related
Circuits in the vlPAG
Closer examination of the pattern of induction of DFosB in
the DR region indicates that immunopositive cell nuclei are
clustered in the lateral margins of the rostral DR, within the
vlPAG (Abrams et al., 2004). This distinctive pattern of
induction is particularly interesting since the vlPAG hasbeen characterized previously as an important neural sub-
strate for passive coping responses (Bandler and Shipley,
1994). IS, which induces primarily passive behavioral
responses, engages the vlPAG (Bandler and Shipley,
1994). Reciprocally, activation of the vlPAG (using electri-
cal stimulation or infusion of excitatory amino acids)
evokes passive behavioral coping reactions of quies-
cence or immobility and hyporeactivity to the environment
(Bandler and Shipley, 1994; Johnson et al., 2004), i.e.,
a behavioral profile similar to the one observed in helpless
mice during the test session. Based on these observa-
tions, we hypothesized that IS-induced accumulation of
DFosB, and subsequent alterations in AP-1 transcription,
may act to desensitize passive coping-related circuits in
the vlPAG.
DFosB in the vlPAGMediates Its Antidepressant-like
Effects by Acting as an Endogenous Antagonist
of AP-1 Sites
Considerable evidence indicates that DFosB can act as
either a transcriptional repressor or activator both in vitro
and in vivo (Chen et al., 1997; Dobrazanski et al., 1991;
McClung and Nestler, 2003; Nakabeppu and Nathans,
1991; Wisdon and Verma, 1993; Yen et al., 1991). The
similar antidepressant-like activity of both DFosB and
DJunD overexpression in the vlPAG (Figure 5) suggests
that DFosB acts in this region after IS as an endogenous
antagonist of AP-1 transcription. Indeed, DJunD, which
lacks an N-terminal transactivation domain, is a truncated
variant of JunD, the major in vivo partner for DFosB (Chen
et al., 1995; Hiroi et al., 1998). In Jun family members, trun-
cation of the highly conserved N-terminal transactivation
domain always creates dominant-negative antagonists
of AP-1-mediated transcription (Brown et al., 1996; Hirai
et al., 1989; Lloyd et al., 1991; Peakman et al., 2003;
Struhl, 1988). This conclusion is also reinforced by the
observation of an opposite (prodepressant) behavioralNeuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc. 295
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tor unambiguously characterized as an AP-1 activator
(Schuermann et al., 1991; Wisdon and Verma, 1993; Yen
et al., 1991). It will be important in future studies to identify
the factors that determine whether DFosB represses or
activates a given target gene.
Substance P Is a Direct Target ofDFosB in the vlPAG
Given the clustering of DFosB-expressing cells at the
periphery of the DR in the vlPAG, we hypothesized that
these cells may express the neuropeptide substance P,
which is known to be expressed in this area with a similar
pattern (Barbaresi, 1998; Harlan et al., 1989; Hurd et al.,
1999; Warden and Young, 1988). Our in situ hybridization
results confirmed that the DFosB immunopositive cell
population is composed primarily of substance P-
expressing neurons. It is not clear which type of neurons
coexpress substance P in this region of the mouse brain.
Although substance P has been shown to be highly colo-
calized with serotonin in the human DR, and to a lesser
extent in the rat’s, this does not seem to be the case in
the mouse, at least at this rostrocaudal level (Chan-Palay
et al., 1978). Colabeling for GAD-67 mRNA suggests that
GABAergic neurons represent only a low proportion of
the DFosB-expressing population, although we cannot
exclude the possibility that some GABAergic neurons in
this region may express other isoforms of GAD (Day
et al., 2004).
The PPT-A gene encoding substance P is reported to
contain AP-1-like sites within its 50 promoter region (Fis-
kerstrand et al., 2000; Paterson et al., 1995). Therefore,
we tested the possibility that IS induction of DFosB in sub-
stance P-positive neurons might feed back and regulate
expression of substance P in these cells. Our ChIP data in-
dicate that the PPT-A gene is in fact a direct target of
DFosB in these neurons: increased binding of DFosB,
but not full-length FosB, occurs at the PPT-A promoter
after IS. This binding activity is delayed and reaches
significance at 24 hr after the administration of IS. The
PPT-A promoter region evaluated for FosB/DFosB bind-
ing spans the nucleotides 420 to 256 upstream of the
transcription start site. Binding of c-Fos containing AP-1
complexes to this regulatoty region, which contains two
tandem AP-1 elements, has been shown to stimulate
PPT-A transcription (Paterson et al., 1995). This is consis-
tent with our interpretation that DFosB, acting as a tran-
scriptional repressor, inhibits PPT-A expression, while
full-length FosB activates it.
DFosB Limits the Activation of Substance P
Neurotransmission during IS: An Adaptive,
Negative-Feedback Mechanism
Substance P neurons within the vlPAG are known to send
their principal ascending projections to the NAc and the
amygdala (Li et al., 1990a, 1990b), a subset of brain
regions implicated in defense responses wherein the
primary receptor for substance P (NK1) is enriched. As
shown in the present study, exposure to experimental296 Neuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc.stresses triggers the release of substance P in the NAc,
whereas blockade of NK1 receptors in this brain region
has antidepressant properties, consistent with the sub-
stantial literature for a role of substance P and NK1 in de-
pression models (Bilkei-Gorzo et al., 2002; Boyce et al.,
2001; Ebner et al., 2004; Rupniak et al., 2000; Smith
et al., 1999). Our in vitro and in vivo results indicate that
the accumulation of DFosB in the vlPAG after IS represses
substance P gene expression in this brain region and de-
sensitizes stress-induced substance P release in the NAc
(Figure 2 and Figure 3). These data support a model in
which repeated activation of substance P neurons in the
vlPAG would lead to an AP-1-mediated desensitization
of the vlPAG-NAc substance P pathway. This desensitiza-
tion, the state of which can be mimicked by NK1 antago-
nists infused into the forebrain (Ebner and Singewald,
2006), would occur only in a subset of animals, and con-
tribute to the inhibition of passive coping-related circuits
and the maintenance of an active behavioral repertoire.
In the rest of the population, in which DFosB levels do
not accumulate sufficiently to repress substance P signal-
ing, a quiescent behavioral repertoire would gradually
develop upon re-exposure to the stressor. In addition to
these effects in distal projection areas, a possible regula-
tion of neuronal networks within the PAG itself, by
substance P expressed and released locally, might be
relevant to the development of learned helplessness
(Barbaresi, 1998; Jansen et al., 1998; Johnson et al.,
2004). Indeed, substance P neurons from the vlPAG
project to, and possibly regulate the activity of, the nearby
serotonin neurons in the DR through a glutamate-
dependent mechanism (Valentino and Commons, 2005).
Accordingly, the infusion of substance P or NK1 agonists
within the DR/vlPAG modulates the firing of serotonin neu-
rons (Valentino and Commons, 2005) and inhibits escape
responses induced by IS (Johnson et al., 2004; Mongeau
et al., 1998).
Our present results provide a fundamentally novel and
testable model for the mechanisms of resilience. Our fu-
ture studies will test the hypothesis that antidepressant
treatments may enhance resilience by stimulating these
same adaptive processes which occur spontaneously in
some, but not all, of the individuals in a population ex-
posed to chronic stress.
EXPERIMENTAL PROCEDURES
Animals
Eight-week-old C57 male mice (Jackson Labs, Bar Harbor, ME) were
used in all but the microdialysis experiments. Animals were housed
four to five per cage in a colony maintained at constant temperature
(23C) with a 12:12 hr light/dark cycle (lights on from 7:00 a.m. to
7:00 p.m.) and ad libitum food and water. All procedures were
approved by the Institutional Animal Care and Use Committee of UT
Southwestern.
For microdialysis experiments male Sprague-Dawley rats weighing
250–350 g (Charles River, Sulzfeld, Germany) were used. Prior to
use, the animals were housed in groups of four to six under controlled
laboratory conditions (12:12 hr light/dark cycle with lights on at 7:00
a.m., 21C ± 1C, 60% humidity, and ad libitum food and water).
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All behavioral procedures in mice, save for the measures of motor co-
ordination and social interaction, were performed using the active
avoidance system of Med Associates (Georgia, VT). This system is
a shuttle box divided into two compartments separated by an auto-
mated door. A grid floor delivers scrambled shocks to either side of
the box. Movements of mice are detected using photocells.
IS, or Training Sessions
On days 1 and 2, mice receiving inescapable shocks (IS group) were
confined in one compartment of the shuttle box and received 120 in-
stances of IS through the grid floor (0.45 mA, 5 s duration). IS was
distributed randomly over 1 hr, with an average intershock interval of
30 s. Animals from the no-IS and no-IS-yoked groups were placed in
the same apparatus for 1 hr, but were not administered any IS.
Escape Trials, or Testing Sessions
Mice were reintroduced into the shuttle box for 15 consecutive escape
trials. During each trial, a continuous shock was delivered and mice
were given the opportunity to escape it by entering the adjacent, un-
electrified compartment. Following a successful escape, the door
was automatically shut and the escape latency recorded. When mice
did not escape within 25 s, the trial was terminated and recorded as
a failure. An additional no-IS-yoked group was used, in which mice
were not given the opportunity to escape shocks during the test ses-
sion, but were individually coupled to the mice from the IS group,
and thus received the exact same amount of shocks.
In experiments including pharmacological treatments, mice were
pretested on day 3, after vehicle administration, to establish baseline
escape latency and balance experimental groups. They were tested
again on day 6 after repeated vehicle or drug administration.
Locomotor Activity
Independent groups of mice were used to determine effects of viral
infusions on locomotor activity. On day 4 and 5 after surgery, animals
were habituated to the shuttle box for 1 hr, and on day 6 locomotor
activity was measured for 15 min.
Sensitivity to Foot Shocks
Independent groups of mice were used to determine the threshold sen-
sitivity to foot shocks. Mice were placed in the shuttle box and after
2 min of habituation, foot shocks were administered every 30 s, starting
at 0.05 mA with a 0.05 mA increment between each shock. The first ap-
pearance of a flinch, a jump, and an audible vocalization were recorded.
Rotarod Test of Motor Coordination
For the rotarod test (IITC Life Science, Woodland Hills, CA), each
mouse was placed on a rotating rod accelerating from 0 to 45 rpm in
60 s. The speed, the latency to fall, and the distance traveled on the
rod were measured. The test was repeated for a total of 8 runs, each
15 min apart.
Social Defeat and Avoidance
Social defeat and avoidance testing were performed according to
previously published protocols (Berton et al., 2006; Tsankova et al.,
2006). Experimental mice were submitted to 10 consecutive days of so-
cial defeat and were evaluated for social approach/avoidance on day
11. Time spent in the interaction zone during the first (no social
target) and second (target present) 2.5 min interaction trials was
evaluated. ‘‘Truly defeated mice’’ were defined as the mice with an
interaction ratio <100%, whereas resilient mice had interaction ratios
>100% (V.K., M. Han, D. Graham, O.B., W. Renthal, Q. Laplant, A. Gra-
ham, S. Russo, M. Lutter, and D. Lagace, unpublished data). For immu-
nohistochemistry, mice were perfused immediately following the termi-
nation of the 5 min test session, 24 hr after the last defeat experience.
Stereotaxic Surgery
Mice were anesthetized using ketamine/xylazine solution, and stereo-
taxic surgery was performed under standard conditions (Hommel
et al., 2003). For bilateral viral infusions in the vPAG area, Hamilton sy-
ringe needles (at a 22 angle) were targeted to 0.56 mm caudal to in-
teraural line, +0.80 mm lateral to midline, and 2.80 mm ventral from
dura. A total of 0.5 ml of purified HSV virus was delivered on eachside over a 4 min period, followed by 6 min of rest. Mice were then
left undisturbed for 3 days (Barrot et al., 2002) and started the first
training session on day 4 post surgery. For verification of injection
sites, brains were processed as described above and slices corre-
sponding to the region of interest were inspected under a microscope.
Animals were rejected when injection sites were found on slices out-
side of the 4.24 mm to 4.72 mm interval respective to bregma, or
outside of the 1 mm2 region described above. Less than 15% of all an-
imals were rejected due to inaccurate injection sites.
To administer drugs into the NAc of awake, freely moving mice, bi-
lateral guide cannulas (26G, 4.5 mm long, 1.5 mm apart, Plastics
One, Roanoke, VA) were chronically implanted in this brain region.
(+1.2 mm anteroposterior [AP], 4.5 mm dorsoventral [DV]) and se-
cured with Cerebond (myNeuroLab, St. Louis, MO). Mice were singly
housed and left to recover for 10 days post surgery. On the day of
the intracerebral infusion, bilateral injectors (33G, projecting 0.5 mm
below the tip of the guide, Plastics One, Roanoke, VA) were inserted
into the guides for the duration of the infusion.
For microdialysis experiments, rats were anesthetized with sodium
pentobarbital/ ketamine. They first received bilateral microinjections
of HSV virus (1 ml on each side over a 6 min period, followed by
2 min of rest) into the vlPAG (coordinates: 7.6 mm AP, +0.5 lateral
(L), 5.8 mm below the surface of the skull). Immediately after vlPAG
infusions, a U-shaped microdialysis probe (1.0 mm membrane, Hemo-
phan, molecular cutoff of 18 kDa) was implanted into each animal’s
NAc (1.6 mm rostral to bregma, 1.2 mm lateral to the midline,
7.8 mm below the surface of the skull). After surgery, rats were housed
individually and left to recover for 3 days, during which they received
daily handling. For histological verification of the localization of viral
injections and microdialysis probe placement, brains were sectioned
and 30 mm coronal sections were stained with cresyl violet.
Microdialysis with Simultaneous Behavioral Analysis
Microdialysis experiments were conducted as described (Ebner et al.,
2004), 3 days after surgery, in rats previously habituated to the proce-
dure room for 24 hr.
Briefly, the probe was connected to a microsyringe pump and
superfused with artificial cerebrospinal fluid (see Ebner et al., 2004
for details). Samples were collected every 30 min and stored at
80C until assay. The first four samples were collected as baseline
release for substance P. At the beginning of the fifth dialysis interval,
animals were transferred for 20 min into a Plexiglas chamber equipped
with a grid floor delivering electric shocks (0.7 mA, ten inescapable
shocks, duration of 5 s each, 1 shock every 120 s). After the last shock,
rats were returned to their home cages and four consecutive 30 min
dialysates were collected. Rats were then transferred from their
home cages to a swim tank (35 3 35 3 42 cm; filled with water at
20C up to a 30 cm height) for 10 min with ongoing dialysis. During
the forced swimming procedure, behavior was videotaped and scored
a posteriori by a trained observer. The behavior of the animals was
assigned to one of the three following behavioral categories: (1) strug-
gling, (2) swimming, and (3) floating. After 10 min the animals were
returned to their home cages and microdialysis was continued for
80 min. The concentration of substance P was measured in micro-
dialysates using a highly sensitive radioimmunoassay (detection limit
0.1 fmol/sample). For detailed descriptions see Ebner et al. (2004).
Drug Treatments
Desipramine (20 mg/kg, Sigma) and RP67580 (5 mg/kg, Tocris) were
given subcutaneously in 10 ml/kg of 1% DMSO. The injections were
performed once daily for four consecutive days, with the last injection
30 min prior to testing in the learned helplessness paradigm. For intra-
cerebral administration, RP67580 to a concentration of 1 mM was
infused in a volume of 1 ml over 5 min, with 0.1% DMSO as a vehicle.
The injector was left in place for 2 extra minutes to allow diffusion of
the drug, and the mice were immediately tested in the learned
helplessness paradigm.Neuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc. 297
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In Situ Hybridization
Immunohistochemistry
Perfusion (conducted immediately after the 15 min test session) and
staining were performed according to standard procedures (Peakman
et al., 2003). For FosB detection we used a 1:500 dilution of a rabbit
polyclonal antiserum (SC7203, SantaCruz Biotechnology, Santa Cruz,
CA), and TPH immunolabeling was performed using a 1:1000 dilution
of a sheep polyclonal antiserum (AB1541, Chemicon, Temecula, CA).
Combined Immunohistochemistry-In Situ Hybridization
Sections were prepared and stained with the FosB antibody as
described above but with the following modifications (Peakman
et al., 2003). Imunolabeling was conducted in RNase-free conditions
and revealed using the avidin-biotin complex method and DAB.
Sections were hybridized overnight at 60C in buffer containing 35S-
labeled RNA probes at 2.0 3 106 counts per minute per slide. Autora-
diography and emulsion procedures were conducted as described
elsewhere (Peakman et al., 2003).
Riboprobes
Antisense 35S-labeled riboprobes were transcribed in the presence of
35S-UTP and purified by using RNA Quickspin columns (Roche, Basel,
Switzerland). PPT-A riboprobe template was a 468 bp fragment corre-
sponding to nucleotides 25–532 of the rat PPT mRNA (Krause et al.,
1987). The template was linearized using HinDIII and transcribed using
T7 RNA polymerase. GAD-67 riboprobe was transcribed using T7 RNA
polymerase from a 360 bp template (nucleotides 1324–1683 of the
feline GAD-67 cDNA, 94% homologous to the murine sequence)
linearized with BamHI (Jones et al., 1994). To produce a ribobrobe
against the SERT, a 470 bp fragment of the murine 5-HTT cDNA
corresponding to the 30UTR of the short spliced variant (nucleotides
143–613 of exon 14; see Bengel et al., 1997) was subcloned into
a TOPO cloning vector (Invitrogen, Carlsbad, CA). For in vitro transcrip-
tion of antisense probe, the vector was linearized using XhoI and
transcribed using SP6 RNA polymerase.
Cell Countings
After double-labeling for FosB and trypyophan hydroxylase, FosB-
positive nuclei were counted from coronal views of the DR (1.1 mm2
area extending 1.1 mm ventral to the tip of the aqueduct and 0.55
mm lateral to the midline). All pictures were captured the same day
under fixed microscope and camera settings. Cell counts from cap-
tured images were averaged for each animal across three consecutive
slides at six independent rostrocaudal levels ranging from 4.24 mm
to 4.96 mm relative to bregma. Rostrocaudal levels were determined
using the pattern of TPH labeling as a landmark (see Figure S1). We
also referred to a published anatomic atlas of TPH immunoreactivity
(Abrams et al., 2004).
Silver Grain Countings
Silver grains were quantified after in situ hybridization using a Leeds
microscope equipped with an x-y-z stage connected to a personal
computer running Bioquant Nova (Bioquant Image Analysis, Nashville,
TN). Pictures were captured from random sites inside of the area of
interest using a 1003 magnification. All the pictures were captured
the same day under fixed microscope and camera settings.
Quantification of Double-Labeling
The relative degree of colocalization of FosB with SERT mRNA, GAD-
67, or PPT-A mRNA was evaluated. Cresyl violet (FosB-negative) or
DAB (FosB-positive) -stained cells were surrounded by a 20 mm diam-
eter circle. Silver grains inside of each defined circle were digitized and
their cumulated area was determined using the Bioquant software. The
same procedure was used to measure grain density at random back-
ground sites. A cell was considered positive for a given mRNA signal
when the density of silver grains was more than three times over the
average background density for a given riboprobe. A total of 150 cells
from three slides in three animals from the IS condition were counted
for each riboprobe. The same approach was used to evaluate the ef-
fect of DFosB expression on the levels of PPT-A mRNA. Grain density
was expressed as a ratio of grain area to cellular area. A total of 60298 Neuron 55, 289–300, July 19, 2007 ª2007 Elsevier Inc.FosB-positive and 150 FosB-negative cells were analyzed from three
slices in three animals from the IS condition.
ChIP Assays
Punch dissections of vlPAG from mice submitted to the IS or control
condition were taken 1 and 24 hr after the end of the second training
session. Tissues were crosslinked, washed, and pooled between three
to four mice. ChIP was performed based on a protocol from Upstate
Biotechnology ChIP kit and published methods (Tsankova et al.,
2004). Aliquots of fixed, sheared chromatin were incubated overnight,
first with mouse anti-FosB antibody (C terminus antibody; Center for
Biomedical Inventions, UT Southwestern), which recognizes full-
length FosB only, followed by rabbit anti-FosB antibody (SC048 Santa
Cruz, CA), which recognizes the middle region of both full-length FosB
and DFosB. Nonimmune IgG was used as a control. The binding of
full-length FosB and DFosB to the PPT-A promoter was determined
by measuring the amount of the PPT-A promoter pulled down in
chromatin immunoprecipitates by use of real-time PCR (ABI Prism
7700, Applied Biosystems, Foster City, CA) using the following
oligonucleotide pairs. For the PPT-A promoter the primers 50-
GCGGAAGTTATTTGGCTGTC-30 and 50-ACAATCTGACGCCCTCC
TC-30 amplified a 164 bp product spanning the portion 420 to
256, a region known to contain an AP-1-AP-1-E Box sequence
necessary for transcriptional regulation of PPT-A by AP-1 complexes
(Paterson et al., 1995). The oligonucleotides used for the synaptophy-
sin control promoter were TCATCTGGTAGAACTGAGCGGTC-30 and
50-GAGGCTGTGGGTTTTAGAGGAA-30.
Viral Vectors
Construction and packaging of viral vectors has been described pre-
viously (Barrot et al., 2002). Transgenes (cDNAs for Lacz, FosB,
DFosB, and DJunD149) were inserted into the HSV amplicon HSV-
PrPUC and packaged into the virus using the helper 5 dl1.2, as
described previously (see Neve et al., 2005). The average titer of viral
stocks was 2.0 3 107 infectious units/ml. Clone #63024, obtained
from the American Type Culture Collection (ATCC, Rockville, MD)
and comprising a 1.67 kb insert encoding mouse JunD, was used
to produce DJunD (or DJunD149) by PCR. DJunD is a truncated
JunD insert that begins at amino acid 149, immediately after the
homologous His that terminates the transactivation domain in all Jun
family members. A FLAG epitope tag, a suitable Kozak sequence,
and an initiating Met residue were also incorporated into the forward
PCR primer. The resulting 617 bp PCR product was gel purified
and subcloned into the HSV PrpUC at the EcoR1 site. This DJunD
is distinct from the previously described endogenous short variant
of JunD, DJunD48, which only lacks 48 amino acids (144 bp) at the
N-terminal extension (Okazaki et al., 1998) and displays only subtle
functional differences when compared with the full-length JunD
protein (Yazgan and Pfarr, 2001, 2002). In contrast, DJunD149
used here has virtually no transactivational activity and, instead,
functions as a dominant-negative of AP-1-mediated transcription
(Hirai et al., 1989; McClung and Nestler, 2003; Peakman et al., 2003;
Struhl, 1988).
Luciferase Assays
Luciferase assays were performed as described previously (Peakman
et al., 2003) using a PPT-A-LUC reporter plasmid (courtesy of J.P.
Quinn, University of Edinburgh, UK). A fragment of thePPT-A promoter
spanning nucleotides –865 to +447 was subcloned into a pGL3-basic
vector (Promega, Madison, WI) expressing firefly luciferase (Fisker-
strand et al., 2000). PC12 cells were cotransfected with the PPT-A-
LUC reporter plasmid and the Renilla luciferase reporter pRL-TK to
control for transfection efficiency. After 24 hr, cells were infected
with HSV-LacZ or HSV-DFosB and harvested after 48 hr. Aliquots nor-
malized for protein concentrations were assayed for reporter gene ac-
tivity using the Dual-Luciferase Reporter Assay System from Promega.
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Dual comparisons were performed using Student’s t tests except for
microdialysis results which were analyzed using nonparametric
Mann-Whitney U-tests. For multiple group comparisons and repeated
measures, we conducted one- or two-way ANOVAs followed by Fisher
post hoc tests.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/55/2/289/DC1/.
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